Boston Partners raised its position in Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) by 17.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 235,180 shares of the company’s stock after buying an additional 34,360 shares during the period. Boston Partners owned 1.37% of Tabula Rasa Healthcare worth $3,540,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the company. TIAA CREF Investment Management LLC boosted its position in Tabula Rasa Healthcare by 108.5% in the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock worth $110,000 after buying an additional 4,232 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in Tabula Rasa Healthcare during the first quarter worth approximately $178,000. Russell Investments Group Ltd. boosted its position in Tabula Rasa Healthcare by 58.1% in the second quarter. Russell Investments Group Ltd. now owns 94,089 shares of the company’s stock worth $1,415,000 after buying an additional 34,565 shares during the last quarter. Hood River Capital Management LLC boosted its position in Tabula Rasa Healthcare by 30.1% in the first quarter. Hood River Capital Management LLC now owns 767,501 shares of the company’s stock worth $10,346,000 after buying an additional 177,774 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in Tabula Rasa Healthcare by 37.2% in the first quarter. Wellington Management Group LLP now owns 782,142 shares of the company’s stock worth $10,544,000 after buying an additional 212,164 shares during the last quarter. Institutional investors and hedge funds own 25.28% of the company’s stock.

Shares of Tabula Rasa Healthcare Inc. (TRHC) opened at 17.77 on Monday. Tabula Rasa Healthcare Inc. has a 12 month low of $10.39 and a 12 month high of $18.25. The firm’s market capitalization is $307.17 million. The firm’s 50-day moving average is $15.45 and its 200 day moving average is $14.23.

Tabula Rasa Healthcare (NASDAQ:TRHC) last announced its quarterly earnings results on Monday, August 7th. The company reported $0.06 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.06. The company had revenue of $29.70 million for the quarter, compared to analysts’ expectations of $27.84 million. Tabula Rasa Healthcare had a negative net margin of 10.27% and a negative return on equity of 9.58%. The firm’s revenue was up 32.6% compared to the same quarter last year. On average, equities research analysts anticipate that Tabula Rasa Healthcare Inc. will post $0.40 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/21/tabula-rasa-healthcare-inc-trhc-shares-bought-by-boston-partners.html.

Several equities research analysts have issued reports on TRHC shares. Stifel Nicolaus cut their price objective on shares of Tabula Rasa Healthcare from $19.00 to $16.00 and set a “buy” rating for the company in a research report on Tuesday, May 2nd. Chardan Capital raised their price objective on shares of Tabula Rasa Healthcare from $19.50 to $21.00 and gave the stock a “buy” rating in a research report on Tuesday, August 8th. UBS AG restated a “buy” rating and set a $17.00 price objective (down from $18.00) on shares of Tabula Rasa Healthcare in a research report on Thursday, May 25th. Zacks Investment Research upgraded shares of Tabula Rasa Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday, May 16th. Finally, Robert W. Baird raised their price objective on shares of Tabula Rasa Healthcare from $17.00 to $18.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 8th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $17.83.

In related news, Director Gordon Tunstall sold 22,759 shares of the company’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $13.76, for a total transaction of $313,163.84. Following the sale, the director now directly owns 5,565 shares in the company, valued at approximately $76,574.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Calvin H. Knowlton sold 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $17.21, for a total transaction of $137,680.00. Following the sale, the chief executive officer now owns 918,362 shares in the company, valued at $15,805,010.02. The disclosure for this sale can be found here. Insiders have sold a total of 46,759 shares of company stock worth $676,604 over the last 90 days. 45.80% of the stock is currently owned by corporate insiders.

Tabula Rasa Healthcare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa Healthcare Inc. (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa Healthcare (NASDAQ:TRHC)

Receive News & Stock Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related stocks with our FREE daily email newsletter.